⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12068011 | 0.96 | — | — | |
| SCHEMBL18576618 | 0.96 | CHRM5 (0.39) | — | |
| SCHEMBL24270373 | 0.96 | — | — | |
| SCHEMBL10187340 | 0.92 | — | — | |
| SCHEMBL91046 | 0.84 | — | — | |
| SCHEMBL17348242 | 0.84 | — | — | |
| SCHEMBL22339184 | 0.83 | ESR1 (0.38) | — | |
| SCHEMBL19519628 | 0.78 | SMN1; SMN2 (0.35) | — | |
| SCHEMBL18571398 | 0.74 | ALDH1A1 (0.40) | — | |
| SCHEMBL20631254 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230320190-A1 | ORGANIC LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-10-05 | — | — | US | disclosed |
| WO-2017035418-A1 | DISUBSTITUTED COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | ACHILLION PHARMACEUTICALS, INC. (US) | 2017-03-02 | — | — | WO | disclosed |
| US-7660042-B2 | Apparatus for crystallizing semiconductor with laser beams | SHARP KABUSHIKI KAISHA (JP) | 2010-02-09 | — | — | US | disclosed |
| WO-2008082725-A1 | PYRIDAZINONE COMPOUNDS | ANADYS PHARMACEUTICALS, INC. (US) | 2008-07-10 | — | — | WO | disclosed |
| WO-2005121130-A2 | CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF INFLAMMATORY DISORDERS | SCHERING CORPORATION (US) | 2005-12-22 | — | — | WO | disclosed |